Media stories about Express Scripts (NASDAQ:ESRX) have been trending somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Express Scripts earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.5527662691758 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the headlines that may have effected Accern Sentiment’s rankings:

ESRX has been the topic of a number of recent research reports. Maxim Group boosted their price target on shares of Express Scripts from $87.00 to $101.00 in a research note on Wednesday, February 28th. TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Jefferies Group set a $80.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a research note on Friday, December 15th. SunTrust Banks set a $82.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a research note on Thursday, December 14th. Finally, BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research report on Thursday, December 14th. Three investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and seven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $81.97.

Express Scripts (NASDAQ ESRX) opened at $77.00 on Wednesday. The company has a quick ratio of 0.55, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $43,916.79, a P/E ratio of 9.83, a P/E/G ratio of 0.96 and a beta of 0.94. Express Scripts has a fifty-two week low of $55.80 and a fifty-two week high of $85.07.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.09 by $0.07. The firm had revenue of $25.38 billion during the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.88 earnings per share. equities analysts anticipate that Express Scripts will post 9.35 EPS for the current fiscal year.

Express Scripts declared that its Board of Directors has initiated a share buyback plan on Monday, December 18th that allows the company to repurchase 45,000,000 shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.

In related news, VP Christine Houston sold 10,104 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the transaction, the vice president now directly owns 87,400 shares of the company’s stock, valued at $6,124,992. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Everett Neville sold 4,895 shares of the company’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The disclosure for this sale can be found here. Insiders sold 21,896 shares of company stock valued at $1,617,903 over the last ninety days. 0.68% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Marea Informative and is the sole property of of Marea Informative. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.mareainformativa.com/2018/03/14/express-scripts-esrx-receiving-somewhat-positive-news-coverage-analysis-shows-updated-updated-updated.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Insider Buying and Selling by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.